B&L contact lens marketing settlements have minimal effect on sales because pricing is unchanged.
This article was originally published in The Gray Sheet
BAUSCH & LOMB/ATTORNEYS GENERAL PACT CODIFIES USE OF ONE TRADE NAME for three types of soft contact lenses previously marketed under different names. Under the terms of a $1.7 mil. settlement with the AGs of 17 states, Bausch & Lomb is required to continue its practice of marketing the three types of lenses under the same trade name. B&L changed to the one-name marketing approach in June.
You may also be interested in...
Bausch & Lomb is required to sell its contact lenses through alternative distribution channels, including mail order companies, as part of a $17.5 mil. proposed settlement of a 1994 antitrust class-action lawsuit.
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.